• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠-脑轴中代谢肽的失调促进高胰岛素血症、肥胖和神经退行性变。

Dysregulation of Metabolic Peptides in the Gut-Brain Axis Promotes Hyperinsulinemia, Obesity, and Neurodegeneration.

作者信息

Green Camille, Zaman Vandana, Blumenstock Kayce, Banik Narendra L, Haque Azizul

机构信息

Department of Neurosurgery, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.

Ralph H. Johnson Veterans Administration Medical Center, 109 Bee Street, Charleston, SC 29401, USA.

出版信息

Biomedicines. 2025 Jan 8;13(1):132. doi: 10.3390/biomedicines13010132.

DOI:10.3390/biomedicines13010132
PMID:39857716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11763097/
Abstract

Metabolic peptides can influence metabolic processes and contribute to both inflammatory and/or anti-inflammatory responses. Studies have shown that there are thousands of metabolic peptides, made up of short chains of amino acids, that the human body produces. These peptides are crucial for regulating many different processes like metabolism and cell signaling, as they bind to receptors on various cells. This review will cover the role of three specific metabolic peptides and their roles in hyperinsulinemia, diabetes, inflammation, and neurodegeneration, as well as their roles in type 3 diabetes and dementia. The metabolic peptides glucagon-like peptide 1 (GLP-1), gastric inhibitor polypeptide (GIP), and pancreatic peptide (PP) will be discussed, as dysregulation within their processes can lead to the development of various inflammatory and neurodegenerative diseases. Research has been able to closely investigate the connections between these metabolic peptides and their links to the gut-brain axis, highlighting changes made in the gut that can lead to dysfunction in processes in the brain, as well as changes made in the brain that can lead to dysregulation in the gut. The role of metabolic peptides in the development and potentially reversal of diseases such as obesity, hyperinsulinemia, and type 2 diabetes will also be discussed. Furthermore, we review the potential links between these conditions and neuroinflammation and the development of neurodegenerative diseases like dementia, specifically Parkinson's disease and Alzheimer's disease.

摘要

代谢肽可以影响代谢过程,并参与炎症和/或抗炎反应。研究表明,人体会产生数千种由短氨基酸链组成的代谢肽。这些肽对于调节许多不同的过程,如新陈代谢和细胞信号传导至关重要,因为它们会与各种细胞上的受体结合。本综述将涵盖三种特定代谢肽的作用及其在高胰岛素血症、糖尿病、炎症和神经退行性变中的作用,以及它们在3型糖尿病和痴呆症中的作用。将讨论代谢肽胰高血糖素样肽1(GLP-1)、胃抑制多肽(GIP)和胰多肽(PP),因为它们过程中的失调会导致各种炎症和神经退行性疾病的发生。研究已经能够密切研究这些代谢肽之间的联系以及它们与肠-脑轴的关联,突出了肠道中发生的变化如何导致大脑中过程的功能障碍,以及大脑中发生的变化如何导致肠道失调。还将讨论代谢肽在肥胖、高胰岛素血症和2型糖尿病等疾病的发展和潜在逆转中的作用。此外,我们回顾了这些病症与神经炎症以及痴呆症等神经退行性疾病(特别是帕金森病和阿尔茨海默病)发展之间的潜在联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800a/11763097/3e3dc85577a5/biomedicines-13-00132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800a/11763097/cf1b187732ca/biomedicines-13-00132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800a/11763097/3e3dc85577a5/biomedicines-13-00132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800a/11763097/cf1b187732ca/biomedicines-13-00132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800a/11763097/3e3dc85577a5/biomedicines-13-00132-g002.jpg

相似文献

1
Dysregulation of Metabolic Peptides in the Gut-Brain Axis Promotes Hyperinsulinemia, Obesity, and Neurodegeneration.肠-脑轴中代谢肽的失调促进高胰岛素血症、肥胖和神经退行性变。
Biomedicines. 2025 Jan 8;13(1):132. doi: 10.3390/biomedicines13010132.
2
Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats.大鼠暴露于鱼藤酮后,代谢肽失调先于高胰岛素血症和炎症出现。
Cells. 2025 Jan 16;14(2):124. doi: 10.3390/cells14020124.
3
A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.通过肠脑轴治疗帕金森病的新策略:胰高血糖素样肽-1 受体途径。
Cell Transplant. 2017 Sep;26(9):1560-1571. doi: 10.1177/0963689717721234.
4
Gut-Derived Peptide Hormone Analogues and Potential Treatment of Bone Disorders in Obesity and Diabetes Mellitus.肠道衍生肽激素类似物与肥胖症和糖尿病中骨疾病的潜在治疗
Clin Med Insights Endocrinol Diabetes. 2024 Mar 13;17:11795514241238059. doi: 10.1177/11795514241238059. eCollection 2024.
5
Role of Antioxidants in Modulating the Microbiota-Gut-Brain Axis and Their Impact on Neurodegenerative Diseases.抗氧化剂在调节微生物群-肠-脑轴中的作用及其对神经退行性疾病的影响。
Int J Mol Sci. 2025 Apr 12;26(8):3658. doi: 10.3390/ijms26083658.
6
NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management?NPYR 调节:在肥胖症和 2 型糖尿病管理方面的下一个重大进展的潜力?
Peptides. 2024 Sep;179:171256. doi: 10.1016/j.peptides.2024.171256. Epub 2024 May 31.
7
Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions.炎症与肠脑轴将肥胖与认知功能障碍联系起来:合理的药物干预措施。
Curr Opin Pharmacol. 2017 Dec;37:87-92. doi: 10.1016/j.coph.2017.10.005. Epub 2017 Nov 5.
8
Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration.基于肠降血糖素的多激动剂肽在神经退行性变的细胞模型中具有神经保护和抗炎作用。
Biomolecules. 2024 Jul 19;14(7):872. doi: 10.3390/biom14070872.
9
Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases.胰高血糖素样肽-1:聚焦神经退行性疾病
Front Neurosci. 2019 Oct 18;13:1112. doi: 10.3389/fnins.2019.01112. eCollection 2019.
10
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment.胰高血糖素样肽-1(GLP-1)受体激动剂与神经炎症:对神经退行性疾病治疗的启示。
Pharmacol Res. 2022 Dec;186:106550. doi: 10.1016/j.phrs.2022.106550. Epub 2022 Nov 11.

引用本文的文献

1
Endogenous Aβ and Exogenous Wheat Gluten Nanostructures: Understanding Peptide Self-Assembly in Disease.内源性淀粉样β蛋白与外源性小麦面筋纳米结构:理解疾病中的肽自组装
ACS Nano. 2025 Sep 2;19(34):30688-30719. doi: 10.1021/acsnano.5c01662. Epub 2025 Aug 8.

本文引用的文献

1
Expanding applications of therapies based on GLP1.基于胰高血糖素样肽1(GLP1)疗法的应用拓展。
Nat Rev Endocrinol. 2025 Feb;21(2):65-66. doi: 10.1038/s41574-024-01066-9.
2
GLP-1 programs the neurovascular landscape.GLP-1 规划神经血管景观。
Cell Metab. 2024 Oct 1;36(10):2173-2189. doi: 10.1016/j.cmet.2024.09.003.
3
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy.胰高血糖素样肽-1 受体:作用机制与治疗进展。
Signal Transduct Target Ther. 2024 Sep 18;9(1):234. doi: 10.1038/s41392-024-01931-z.
4
Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials.胰高血糖素样肽-1 受体激动剂与胃肠道癌症风险:一项随机对照试验的系统评价和荟萃分析。
Pharmacol Res. 2024 Oct;208:107401. doi: 10.1016/j.phrs.2024.107401. Epub 2024 Sep 7.
5
The unexpected role of GIP in transforming obesity treatment.GIP在转变肥胖症治疗方法中的意外作用。
Trends Endocrinol Metab. 2025 Apr;36(4):330-338. doi: 10.1016/j.tem.2024.07.022. Epub 2024 Aug 27.
6
Glucagon-Like Peptide-1 Receptor Agonists and Atrial Fibrillation Recurrence After Ablation: A Fire Without the Smoke?胰高血糖素样肽-1受体激动剂与消融术后房颤复发:无烟雾的火灾?
JACC Clin Electrophysiol. 2024 Aug;10(8):1940-1941. doi: 10.1016/j.jacep.2024.07.004.
7
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists.胰高血糖素样肽-1(GLP-1)及双重葡萄糖依赖性促胰岛素多肽(GIP)/GLP-1受体激动剂的作用机制与治疗应用
Front Endocrinol (Lausanne). 2024 Jul 24;15:1431292. doi: 10.3389/fendo.2024.1431292. eCollection 2024.
8
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes.GLP1-GIP 受体双重激动剂:治疗 2 型糖尿病的一种有前途的新进展。
Acta Diabetol. 2024 Aug;61(8):941-950. doi: 10.1007/s00592-024-02300-6. Epub 2024 Jun 3.
9
The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue.葡萄糖依赖性胰岛素多肽在脂肪组织中的相互作用。
J Endocrinol. 2024 Apr 27;261(3). doi: 10.1530/JOE-23-0361. Print 2024 Jun 1.
10
Reactive gliosis in traumatic brain injury: a comprehensive review.创伤性脑损伤中的反应性胶质增生:综述
Front Cell Neurosci. 2024 Feb 28;18:1335849. doi: 10.3389/fncel.2024.1335849. eCollection 2024.